FORMULARY

INSIGHTS

SEE US IN PharmExec

See Our Latest Research Offerings:

Payer Access Dynamics in AMD/DME/RVO

Short- and Long-Term Manufacturer Strategies in Biosims

BECAUSE THERE IS SO MUCH MORE TO FORMULARY DECISIONS

THAN WHAT PHARMA CAN SEE

We help biopharmaceutical investors, marketers, and leaders better understand critical payer perceptions of their product and its competitors.

MAJOR CLIENTS IN 2020 INCLUDE:

1/2

We connect our clients with P&T participants who share their unbiased perspectives on drug labels, clinical trials and other inputs that determine formulary placement.

WE TAKE YOU WHERE NO ONE ELSE CAN

INSIDE CURRENT AND REAL-WORLD P&T EVALUATIONS OF ANY DRUG

An insider's view of current, real-world P&T drug evaluations

Detailed grading and commentary regarding selected clinical evidence

Direct, section-by-section comparison of selected drug labels

Multiple-choice and open-text surveying of current formulary decision makers